Latest Sunitinib Stories
COVENTRY health chiefs are supporting a draft decision to reject four new cancer drugs for patients with advanced kidney cancer. The National Institute for Health and Clinical Excellence (Nice) decided that sunitinib, bevacizumab, sorafenib and Torisel are not a cost-effective use of NHS cash.
By Barry Nelson A CANCER patient who has survived in the past year because of a wonder drug has condemned plans to deny it to other patients because of the cost. Stan Craddock, 63, from Darlington, said he survived the past ten months because of the drug Sutent.
TWO cancer sufferers from Warwickshire have been left angered by a national medical board's decision not to fund a life-lengthening wonder drug. As featured in the Telegraph, Ade Cure, from Wellesbourne, and Colin Howe, from Rugby, are both dying of kidney cancer.
By Barry Nelson NORTH-EAST health bosses say newly referred kidney cancer patients will continue to receive an expensive drug for the time being. The reassurance from the North of England Cancer Network came after Wednesday?s announcement of draft guidance rejecting four new cancer drugs.
The UK's cost-effectiveness watchdog NICE has delivered another blow to the developers of targeted cancer therapies by recommending against the use of four new kidney cancer drugs in the UK.
Britain's National Health Service said it rejected four new drugs designed to treat advanced kidney cancer because the cost is too high.
By Ian Johnston CAMPAIGNERS EXPRESSED outrage yesterday at a decision to deny four drug treatments to NHS patients with advanced kidney cancer.
By JEREMY LAURANCE The big question Why are we asking this now? CANCER CHARITIES, kidney specialists and campaigners were outraged yesterday when the National Institute for Clinical Excellence (Nice), announced that it had rejected four new drugs for advanced kidney cancer as too expensive for the NHS.
By JANE KIRBY PATIENTS with advanced kidney cancer will be denied four treatments on the NHS under new guidelines published yesterday.
By Greg Tindle A WELSH cancer expert has described as "an outrage" plans to deny patients with advanced kidney cancer four types of drug treatment on the NHS.
- The governor of a province or people.